Provention Bio November 2021 Autoimmunity Prevention

Provention Bio presentation on intercepting autoimmunity to prevent chronic diseases, focusing on the clinical development and regulatory pathway of teplizumab. Discusses the company's mission to identify autoimmune diseases early and prevent debilitating outcomes through innovative therapeutic approaches.